SG11201505529SA - Oral electrolyte solution containing lactoferrin and uses thereof - Google Patents

Oral electrolyte solution containing lactoferrin and uses thereof

Info

Publication number
SG11201505529SA
SG11201505529SA SG11201505529SA SG11201505529SA SG11201505529SA SG 11201505529S A SG11201505529S A SG 11201505529SA SG 11201505529S A SG11201505529S A SG 11201505529SA SG 11201505529S A SG11201505529S A SG 11201505529SA SG 11201505529S A SG11201505529S A SG 11201505529SA
Authority
SG
Singapore
Prior art keywords
solution containing
electrolyte solution
containing lactoferrin
oral electrolyte
oral
Prior art date
Application number
SG11201505529SA
Inventor
Juan M Gonzalez
Dattatreya Banavara
John D Alvey
Original Assignee
Mjn Us Holdings Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mjn Us Holdings Llc filed Critical Mjn Us Holdings Llc
Publication of SG11201505529SA publication Critical patent/SG11201505529SA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C17/00—Buttermilk; Buttermilk preparations
    • A23C17/02—Buttermilk; Buttermilk preparations containing, or treated with, microorganisms or enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
SG11201505529SA 2013-03-11 2014-02-11 Oral electrolyte solution containing lactoferrin and uses thereof SG11201505529SA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13/794,014 US20140255365A1 (en) 2013-03-11 2013-03-11 Oral Electrolyte Solution Containing Lactoferrin and Uses Thereof
PCT/US2014/015811 WO2014143471A1 (en) 2013-03-11 2014-02-11 Oral electrolyte solution containing lactoferrin and uses thereof

Publications (1)

Publication Number Publication Date
SG11201505529SA true SG11201505529SA (en) 2015-08-28

Family

ID=50239940

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201505529SA SG11201505529SA (en) 2013-03-11 2014-02-11 Oral electrolyte solution containing lactoferrin and uses thereof

Country Status (14)

Country Link
US (1) US20140255365A1 (en)
EP (1) EP2968305A1 (en)
CN (1) CN105120888A (en)
AR (1) AR095082A1 (en)
AU (1) AU2014228654B2 (en)
BR (1) BR112015020864A2 (en)
CA (1) CA2904221A1 (en)
HK (1) HK1218070A1 (en)
MX (1) MX2015011540A (en)
PE (1) PE20151883A1 (en)
PH (1) PH12015501803A1 (en)
RU (1) RU2015132613A (en)
SG (1) SG11201505529SA (en)
WO (1) WO2014143471A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11197917B2 (en) 2017-12-01 2021-12-14 ByHeart, Inc. Formulations for nutritional support in subjects in need thereof
GR1009632B (en) 2018-07-09 2019-10-25 Ιουλια Κλεωνος Τσετη Nutritional supplement for the oral administration of a combination of lactoferrin, xyloglucan, proanthocyanidin and simethicone against the infections of the gastrointestinal and urinary tract

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE61701B1 (en) 1986-07-17 1994-11-30 Morinaga Milk Industry Co Ltd Process for producing bovine lactoferrin in high purity
EP1142484A2 (en) 1994-02-16 2001-10-10 Pharming Intellectual Property BV Isolation of lactoferrin from milk
SE523771C2 (en) * 1999-05-21 2004-05-18 Probi Ab Sports drinks containing micronutrients in combination with live lactobacilli
NZ535784A (en) 2002-03-07 2006-02-24 Upfront Chromatography As A process of isolating lactoferrin
BRPI0616456A2 (en) * 2005-09-28 2011-06-21 Ventria Bioscience formulation to prevent or treat enteric disorders, diarrhea or inflammatory bowel disease or to promote beneficial intestinal flora growth, oral rehydration solution and oral rehydration formulation in the form of a powder or liquid concentrate
EP1974735A1 (en) * 2007-03-28 2008-10-01 Nestec S.A. Reduction of risk of diarrhoea
IT1392672B1 (en) * 2009-01-12 2012-03-16 Wyeth Consumer Healthcare S P A COMPOSITIONS INCLUDING PROBIOTIC COMPONENTS AND PREBIOTICS AND MINERAL SALTS, WITH LACTOFERRINA
US20120171328A1 (en) 2011-01-05 2012-07-05 Dattatreya Banavara Composition comprising heat labile milk proteins and process for preparing same
US20130095204A1 (en) * 2011-10-14 2013-04-18 Zeina Jouni Nutritional phytonutrient compositions

Also Published As

Publication number Publication date
PH12015501803A1 (en) 2015-11-09
EP2968305A1 (en) 2016-01-20
RU2015132613A (en) 2017-04-13
CA2904221A1 (en) 2014-09-18
AU2014228654B2 (en) 2018-02-15
PE20151883A1 (en) 2016-01-17
US20140255365A1 (en) 2014-09-11
BR112015020864A2 (en) 2017-07-18
WO2014143471A1 (en) 2014-09-18
CN105120888A (en) 2015-12-02
MX2015011540A (en) 2016-02-05
AR095082A1 (en) 2015-09-16
HK1218070A1 (en) 2017-02-03
AU2014228654A1 (en) 2015-08-06

Similar Documents

Publication Publication Date Title
ZA201601085B (en) Anti-garp protein and uses thereof
HK1223975A1 (en) Nanobubble-containing composition and use thereof
EP3065205A4 (en) Electrode and cell having electrode
EP3016199A4 (en) Electrolytic solution and battery
GB201321693D0 (en) Composition and uses thereof
EP3080855A4 (en) Electrochemical cells and components thereof
EP2894645A4 (en) Electrolyte solution and electrochemical device
EP2985314A4 (en) Contacting component and structure containing said contacting component
HK1219175A1 (en) Electrochemical cell
EP3067906A4 (en) Electrochemical device
EP2999341A4 (en) Stabilized hypochlorous acid solution and use thereof
AP2016009128A0 (en) Cyclic thienouracil-carboxamides and use thereof
GB201309753D0 (en) Electrolysis cell and electrode
EP2853591A4 (en) Human hepatoma cell line hlcz01 and uses thereof
GB201211775D0 (en) An electrode and use thereof
EP2983472A4 (en) Ionic liquids and uses thereof
HK1218070A1 (en) Oral electrolyte solution containing lactoferrin and uses thereof
GB2519937B (en) Electrochemical sensor
GB201305297D0 (en) Novel agents and uses thereof
GB201217826D0 (en) The Baubury beehive and slotted base
ZA201601880B (en) Hetero-transglycosylase and uses thereof
PL3084860T3 (en) Battery terminal
EP2979093A4 (en) Rare cell concentration
GB201320632D0 (en) Electrochemical cells and components thereof
GB201319932D0 (en) Electrochemical materials and their manufacture